FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149450175> ?p ?o ?g. }

• W2149450175 endingPage "246" @default.
• W2149450175 startingPage "240" @default.
• W2149450175 abstract "Introduction Cyclooxygenase (COX2) expression in primary breast cancer correlates with a worse prognosis. We reported previously that COX2 expression in MCF10A breast epithelial cells of basal subtype induces genomic instability. To understand the role of COX2 in estrogen receptor-positive (non-basal) breast cancer, we transfected the MCF7 cell line with COX2 and analyzed its chromosomal profile, BCL2 protein expression, and resistance to doxorubicin. We also analyzed cell cultures grown as mammospheres to determine whether COX2 expression affects the cancer-initiating (“stem”) cell phenotype in MCF7 cells. Methods MCF7 Tet On cells (obtained from Clontech) were stably transfected with pTRE2pur-COX2 or pTRE2pur-COX2-GFP to produce COX2 or COX2-GFP protein, respectively. BCL2 protein was detected by Western blotting. Sensitivity of cells to drug treatment was analyzed by MTT assay. Groups were compared using Chi-Square test. We analyzed the genomic instability phenotype by chromosome analysis of control and COX2 transfected metaphase-arrested MCF7 cells after Giemsa staining. We assessed the tumorigenic potential of cells grown as mammospheres with a clonogenic assay. Results Cytogenetic analysis of early passage COX2 transfected MCF7 cells demonstrated significant genomic instability as compared to parental MCF7 cells. COX2 overexpression was associated with a significant increase in chromosomal aberrations (chromatid breaks, chromosome fusions, C anaphase). COX2 transfected MCF7 cells produced a significantly higher level of the anti-apoptotic protein BCL2 than the parental cells. In a functional assay, we found that COX2 expression correlated with increased resistance to doxorubicin. In a complimentary approach to determine tumorigenic potential of cells, we found that COX2 increased the ability of MCF7 cells to grow as mammospheres in culture, which correlated with an increase in clonogenic efficiency. Conclusions We found that COX2 expression in MCF7 breast cancer cells induced genomic instability, BCL2 expression, and doxorubicin resistance, thus making them significantly more tumorigenic. This data suggests that COX-2 may be an important target for breast cancer treatment." @default.
• W2149450175 created "2016-06-24" @default.
• W2149450175 creator A5002283900 @default.
• W2149450175 creator A5004443463 @default.
• W2149450175 creator A5026737814 @default.
• W2149450175 creator A5037147613 @default.
• W2149450175 creator A5042475462 @default.
• W2149450175 creator A5063659172 @default.
• W2149450175 creator A5087668765 @default.
• W2149450175 date "2008-06-01" @default.
• W2149450175 modified "2023-09-26" @default.
• W2149450175 title "Cyclooxygenase-2 Induces Genomic Instability, BCL2 Expression, Doxorubicin Resistance, and Altered Cancer-Initiating Cell Phenotype in MCF7 Breast Cancer Cells" @default.
• W2149450175 cites W143578400 @default.
• W2149450175 cites W185729446 @default.
• W2149450175 cites W1990316038 @default.
• W2149450175 cites W2003493239 @default.
• W2149450175 cites W2017583063 @default.
• W2149450175 cites W2020755798 @default.
• W2149450175 cites W2023316892 @default.
• W2149450175 cites W2023427658 @default.
• W2149450175 cites W2037862743 @default.
• W2149450175 cites W2052345892 @default.
• W2149450175 cites W2072336398 @default.
• W2149450175 cites W2075421196 @default.
• W2149450175 cites W2083256941 @default.
• W2149450175 cites W2093921289 @default.
• W2149450175 cites W2125439393 @default.
• W2149450175 cites W2127617517 @default.
• W2149450175 cites W2142739240 @default.
• W2149450175 cites W2145149010 @default.
• W2149450175 cites W2165113897 @default.
• W2149450175 doi "https://doi.org/10.1016/j.jss.2008.02.026" @default.
• W2149450175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18498876" @default.
• W2149450175 hasPublicationYear "2008" @default.
• W2149450175 type Work @default.
• W2149450175 sameAs 2149450175 @default.
• W2149450175 citedByCount "45" @default.
• W2149450175 countsByYear W21494501752012 @default.
• W2149450175 countsByYear W21494501752013 @default.
• W2149450175 countsByYear W21494501752014 @default.
• W2149450175 countsByYear W21494501752015 @default.
• W2149450175 countsByYear W21494501752016 @default.
• W2149450175 countsByYear W21494501752017 @default.
• W2149450175 countsByYear W21494501752019 @default.
• W2149450175 countsByYear W21494501752020 @default.
• W2149450175 countsByYear W21494501752021 @default.
• W2149450175 countsByYear W21494501752023 @default.
• W2149450175 crossrefType "journal-article" @default.
• W2149450175 hasAuthorship W2149450175A5002283900 @default.
• W2149450175 hasAuthorship W2149450175A5004443463 @default.
• W2149450175 hasAuthorship W2149450175A5026737814 @default.
• W2149450175 hasAuthorship W2149450175A5037147613 @default.
• W2149450175 hasAuthorship W2149450175A5042475462 @default.
• W2149450175 hasAuthorship W2149450175A5063659172 @default.
• W2149450175 hasAuthorship W2149450175A5087668765 @default.
• W2149450175 hasConcept C109541995 @default.
• W2149450175 hasConcept C117262875 @default.
• W2149450175 hasConcept C121608353 @default.
• W2149450175 hasConcept C143425029 @default.
• W2149450175 hasConcept C153911025 @default.
• W2149450175 hasConcept C178169997 @default.
• W2149450175 hasConcept C2994423619 @default.
• W2149450175 hasConcept C502942594 @default.
• W2149450175 hasConcept C54009773 @default.
• W2149450175 hasConcept C54355233 @default.
• W2149450175 hasConcept C552990157 @default.
• W2149450175 hasConcept C81885089 @default.
• W2149450175 hasConcept C86803240 @default.
• W2149450175 hasConcept C96232424 @default.
• W2149450175 hasConceptScore W2149450175C109541995 @default.
• W2149450175 hasConceptScore W2149450175C117262875 @default.
• W2149450175 hasConceptScore W2149450175C121608353 @default.
• W2149450175 hasConceptScore W2149450175C143425029 @default.
• W2149450175 hasConceptScore W2149450175C153911025 @default.
• W2149450175 hasConceptScore W2149450175C178169997 @default.
• W2149450175 hasConceptScore W2149450175C2994423619 @default.
• W2149450175 hasConceptScore W2149450175C502942594 @default.
• W2149450175 hasConceptScore W2149450175C54009773 @default.
• W2149450175 hasConceptScore W2149450175C54355233 @default.
• W2149450175 hasConceptScore W2149450175C552990157 @default.
• W2149450175 hasConceptScore W2149450175C81885089 @default.
• W2149450175 hasConceptScore W2149450175C86803240 @default.
• W2149450175 hasConceptScore W2149450175C96232424 @default.
• W2149450175 hasIssue "2" @default.
• W2149450175 hasLocation W21494501751 @default.
• W2149450175 hasLocation W21494501752 @default.
• W2149450175 hasOpenAccess W2149450175 @default.
• W2149450175 hasPrimaryLocation W21494501751 @default.
• W2149450175 hasRelatedWork W2037515857 @default.
• W2149450175 hasRelatedWork W2040998738 @default.
• W2149450175 hasRelatedWork W2053393868 @default.
• W2149450175 hasRelatedWork W2163799657 @default.
• W2149450175 hasRelatedWork W2347120132 @default.
• W2149450175 hasRelatedWork W2379152510 @default.
• W2149450175 hasRelatedWork W2384261171 @default.
• W2149450175 hasRelatedWork W2394757359 @default.
• W2149450175 hasRelatedWork W2462877824 @default.
• W2149450175 hasRelatedWork W2885029506 @default.

• next